📰 Attribute Analysis News
Page 4 - Attribute Analysis News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Attribute Analysis. Real-time updates on events, politics, business and more.
May 22, 2023
According to DelveInsight's estimates, the sickle cell disease market size in the 7MM is expected to show positive growth, during the forecast period (2023-2032), mainly attributed to the increasing
May 17, 2023
/PRNewswire/ -- DelveInsights Chemotherapy-induced Peripheral Neuropathy Market Insights report includes a comprehensive understanding of current treatment...
May 17, 2023
The chemotherapy-induced peripheral neuropathy market is expected to show positive growth, mainly attributed to the increased diagnosed prevalence and also the launch of upcoming therapies during
May 16, 2023
The psychosis in Parkinson's and Alzheimer's disease market size shall grow during the forecast period (2023-2032). This increase will be due to rising disease awareness and improving diagnosis
May 16, 2023
/PRNewswire/ -- DelveInsights Psychosis in Parkinsons and Alzheimers Disease Market Insights report includes a comprehensive understanding of current...
May 11, 2023
The cocaine use disorder market is expected to increase owing to the increasing awareness and increasing diagnosed prevalent population. Moreover, the expected launch of emerging therapies,
May 9, 2023
The PD-1 and PD-L1 inhibitors market is anticipated to be driven in the coming years due to the rise in novel drugs and therapies and the increase in healthcare spending across the world. In
May 9, 2023
/PRNewswire/ -- DelveInsights Acute Ischemic Stroke Market Insights report includes a comprehensive understanding of current treatment practices, acute...
May 9, 2023
The dynamics of the acute ischemic stroke (AIS) market are anticipated to change during the forecast period (2023-2032) owing to the improved knowledge of stroke pathophysiology, awareness of
May 3, 2023
The uveitis market is expected to increase owing to the increasing awareness, improved diagnosis, and rising diagnosed prevalent population. In addition, the expected launch of emerging therapies